Paul Tudor Jones Zai Lab LTD Transaction History

Tudor Investment Corp Et Al

  • $19.2 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$54.9 - $105.21 $779,799 - $1.49 Million
-14,204 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$105.0 - $178.37 $1.49 Million - $2.53 Million
14,204 New
14,204 $1.5 Million
Q2 2021

Aug 16, 2021
SELL
$125.11 - $180.0 $284,375 - $409,140
-2,273 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$126.27 - $191.71 $287,011 - $435,756
2,273 New
2,273 $303,000

Others Institutions Holding ZLAB

# of Institutions
116
Shares Held
40.8M
Call Options Held
63.1K
Put Options Held
420K
View Full List

About Zai Lab Ltd

ZLAB Quotes by TradingView
  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.02B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email